Search research articles
Contact Us
Filters
Showing results (101-110 of 143) with videos related to
Page
of 15
Sort By:
Cancer Diagnosis & Prognosis
|
January 6, 2025
Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
December 3, 2024
Selective Synergy of Recombinant Methioninase Plus Docetaxel Against Docetaxel-resistant and -sensitive Fibrosarcoma Cells Compared to Normal Fibroblasts
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
October 30, 2024
Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)
|
May 2, 2020
Oral Recombinant Methioninase Inhibits Diabetes Onset in Mice on a High-fat Diet
Yoshihiko Tashiro, Qinghong Han, Yuying Tan, et al.
Biochemical and Biophysical Research Communications
|
December 31, 2022
Synergy of oral recombinant methioninase (rMETase) and 5-fluorouracil on poorly differentiated gastric cancer
Masuyo Miyake, Kentaro Miyake, Qinghong Han, et al.
Frontiers in Oncology
|
November 21, 2022
Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation
Yusuke Aoki, Qinghong Han, Yasunori Tome, et al.
Anticancer Research
|
January 31, 2025
Recombinant Methioninase (rMETase) Synergistically Sensitizes Ivermectin-resistant MCF-7 Breast Cancer Cells 9.9 Fold to Low-dose Ivermectin
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Cancer Genomics & Proteomics
|
October 28, 2024
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Biochemical and Biophysical Research Communications
|
December 17, 2019
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model
Takashi Higuchi, Qinghong Han, Kentaro Miyake, et al.
Anticancer Research
|
August 28, 2024
Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical Problem
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 143) with videos related to
Sort By:
Page
of 15
Cancer Diagnosis & Prognosis
|
January 6, 2025
Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
December 3, 2024
Selective Synergy of Recombinant Methioninase Plus Docetaxel Against Docetaxel-resistant and -sensitive Fibrosarcoma Cells Compared to Normal Fibroblasts
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
October 30, 2024
Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)
|
May 2, 2020
Oral Recombinant Methioninase Inhibits Diabetes Onset in Mice on a High-fat Diet
Yoshihiko Tashiro, Qinghong Han, Yuying Tan, et al.
Biochemical and Biophysical Research Communications
|
December 31, 2022
Synergy of oral recombinant methioninase (rMETase) and 5-fluorouracil on poorly differentiated gastric cancer
Masuyo Miyake, Kentaro Miyake, Qinghong Han, et al.
Frontiers in Oncology
|
November 21, 2022
Reversion of methionine addiction of osteosarcoma cells to methionine independence results in loss of malignancy, modulation of the epithelial-mesenchymal phenotype and alteration of histone-H3 lysine-methylation
Yusuke Aoki, Qinghong Han, Yasunori Tome, et al.
Anticancer Research
|
January 31, 2025
Recombinant Methioninase (rMETase) Synergistically Sensitizes Ivermectin-resistant MCF-7 Breast Cancer Cells 9.9 Fold to Low-dose Ivermectin
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Cancer Genomics & Proteomics
|
October 28, 2024
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Biochemical and Biophysical Research Communications
|
December 17, 2019
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model
Takashi Higuchi, Qinghong Han, Kentaro Miyake, et al.
Anticancer Research
|
August 28, 2024
Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical Problem
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Page
of 15